\-\ Texto\\:\\ \ \(0\)\
\-\ bitemporal\\ visual\\ field\\ defects\\.\ \(1\)\
\-\ ongoing\ \(26\)\
\-\ suprasellar\\ mass\\.\ \(4\)\
\-\ craniopharyngioma\ \(24\)\
\-\ craniopharyngioma\ \(24\)\
\-\ 37\\ y\\/o\\ female\\ with\\ 1\\ month\\ hx\\ of\\ recurrent\\ sharp\\,\\ right\\ temporal\\ ha\\ and\\ 2\\ week\\ hx\\ of\\ worsening\\ bitemporal\\ visual\\ field\\ defects\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bitemporal\\:\\ 0\\.33571831676259534\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.2513921657121171\ \(0\)\
\-\ field\\:\\ 0\\.24359453472906578\ \(0\)\
\-\ hx\\:\\ 0\\.23503060807199588\ \(0\)\
\-\ defects\\:\\ 0\\.21806496087470803\ \(0\)\
\-\ visual\\:\\ 0\\.215215333408733\ \(0\)\
\-\ ha\\:\\ 0\\.15777845022325968\ \(0\)\
\-\ ongoing\\:\\ 0\\.14948697831892643\ \(0\)\
\-\ suprasellar\\:\\ 0\\.12935098168352294\ \(0\)\
\-\ sharp\\:\\ 0\\.12849621338722422\ \(0\)\
\-\ 37\\:\\ 0\\.11927027352548493\ \(0\)\
\-\ recurrent\\:\\ 0\\.1001675630868077\ \(0\)\
\-\ temporal\\:\\ 0\\.09505252437817047\ \(0\)\
\-\ worsening\\:\\ 0\\.0934577769555777\ \(0\)\
\-\ week\\:\\ 0\\.08061153939800633\ \(0\)\
\-\ month\\:\\ 0\\.07121151502223914\ \(0\)\
\-\ y\\/o\\:\\ 0\\.0657396952727678\ \(0\)\
\-\ 1\\:\\ 0\\.05648128799888075\ \(0\)\
\-\ 2\\:\\ 0\\.051114013791959616\ \(0\)\
\-\ female\\:\\ 0\\.04879889642910649\ \(0\)\
\-\ mass\\:\\ 0\\.033012805748543456\ \(0\)\
\-\ right\\:\\ 0\\.02504532525306713\ \(0\)\
\-\ \\,\\:\\ 0\\.007519724042146871\ \(0\)\
\-\ of\\:\\ 0\\.006472433377666023\ \(0\)\
\-\ and\\:\\ 0\\.00500025015922829\ \(0\)\
\-\ with\\:\\ 0\\.003250116002496937\ \(0\)\
\-\ \\.\\:\\ 0\\.0029582946747788563\ \(0\)\
